Otmane Boussif

Otmane Boussif has a diverse and extensive work experience in the biotechnology and pharmaceutical industry. Otmane is currently serving as the Chief Technology Officer at Anjarium Biosciences since October 2022. Prior to this, they worked at Sensorion as the Chief Technical Officer from August 2021 to September 2022.

Before joining Sensorion, Otmane worked at Novartis in various leadership roles. Otmane served as the Head of Global Tech Dev. Cell Therapies & Viral Vectors from July 2020 to June 2021. Otmane also held the position of Global Head Cell & Gene Therapy TRD from April 2019 to June 2020. Furthermore, they were the Global Head of Early Phase Development NBEs from October 2017 to April 2019, and the Global Head of Drug Product Development from May 2016 to October 2017. Otmane started their journey at Novartis as the Head of Late Stage Biologics Process & Pharmaceutical Development, BPRD from June 2015 to May 2016.

Prior to Novartis, Otmane Boussif gained significant experience at Sanofi. Otmane held the position of Director, Purification & Formulation Platform, BRD from December 2010 to June 2015. Otmane also served as the Head of Formulation Development - Biologics Center from August 2006 to November 2010.

Otmane Boussif began their career at EMD Serono, Inc. as DSP & Preformulation from August 2004 to August 2006. Before that, they worked at Sanofi as the Head of Formulation Dev. & Protein Preclinical Manufacturing from August 2000 to August 2004.

Their earliest work experience as a Research Scientist was at Transgene in the Biochemistry Department from January 1997 to August 2000.

Overall, Otmane Boussif has held various high-level positions throughout their career, showcasing their expertise in technology development, formulation, and development of biologics and cell therapies.

Otmane Boussif completed their education from 1986 to 1996 at the University of Strasbourg. They obtained a Doctor of Science degree in Applied Biological and Fundamental Sciences during this period.